HK1079118A1 - Stable injectable diclofenac compositions - Google Patents

Stable injectable diclofenac compositions

Info

Publication number
HK1079118A1
HK1079118A1 HK06100808A HK06100808A HK1079118A1 HK 1079118 A1 HK1079118 A1 HK 1079118A1 HK 06100808 A HK06100808 A HK 06100808A HK 06100808 A HK06100808 A HK 06100808A HK 1079118 A1 HK1079118 A1 HK 1079118A1
Authority
HK
Hong Kong
Prior art keywords
diclofenac
cyclodextrin
salt
stable injectable
pharmaceutically acceptable
Prior art date
Application number
HK06100808A
Other languages
English (en)
Inventor
Lawrence John Penkler
Original Assignee
Shimoda Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34826259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1079118(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shimoda Biotech Pty Ltd filed Critical Shimoda Biotech Pty Ltd
Publication of HK1079118A1 publication Critical patent/HK1079118A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK06100808A 2004-03-10 2006-01-18 Stable injectable diclofenac compositions HK1079118A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55135104P 2004-03-10 2004-03-10

Publications (1)

Publication Number Publication Date
HK1079118A1 true HK1079118A1 (en) 2006-03-31

Family

ID=34826259

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06100808A HK1079118A1 (en) 2004-03-10 2006-01-18 Stable injectable diclofenac compositions

Country Status (20)

Country Link
US (2) US20050238674A1 (fr)
EP (2) EP1767219B1 (fr)
JP (1) JP2007528384A (fr)
KR (1) KR20070028331A (fr)
AT (2) ATE454905T1 (fr)
AU (1) AU2004317520B2 (fr)
BR (1) BRPI0418474A (fr)
CA (1) CA2555429C (fr)
CY (1) CY1106824T1 (fr)
DE (2) DE602004025151D1 (fr)
DK (2) DK1574221T3 (fr)
ES (2) ES2336034T3 (fr)
HK (1) HK1079118A1 (fr)
IL (1) IL177529A (fr)
MX (1) MXPA06010336A (fr)
PL (2) PL1767219T3 (fr)
PT (2) PT1767219E (fr)
SI (2) SI1574221T1 (fr)
WO (2) WO2005092387A1 (fr)
ZA (2) ZA200607631B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007009312A (es) 2005-02-01 2008-03-10 Troikaa Pharmaceuticals Ltd Preparaciones inyectables de diclofenaco y sus sales farmaceuticamente aceptables.
US20060205080A1 (en) * 2005-03-01 2006-09-14 David Frey Formulations for therapeutic viruses having enhanced storage stability
KR20170123724A (ko) 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 저 투여량의 디클로페낙 및 베타-사이클로덱스트린 제형
KR20090010953A (ko) * 2006-03-28 2009-01-30 자블린 파머슈티칼스 인코포레이티드 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형
AU2012209035B9 (en) * 2006-03-28 2014-05-22 Javelin Pharmaceuticals, Inc. Formulations of low dose diclofenac and beta-cyclodextrin
CL2007003877A1 (es) 2007-12-28 2008-06-27 Univ De Concepcion Lab Androma Composicion farmaceutica que comprende un complejo de inclusion formado por disulfiram y una ciclodextrina; y su uso para el tratamiento de la dependencia de alcohol y cocaina.
US20100022652A1 (en) * 2008-07-28 2010-01-28 Tyco Healthcare Group Lp Antimicrobial and Anticoagulant Compositions and Methods
CA2755069A1 (fr) 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Conjugues anti-inflammatoires et anti-oxydants utiles pour traiter des troubles metaboliques
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
BR112014001335A2 (pt) * 2011-07-20 2017-02-21 Hospira Inc método para tratar dor pós-operatória em um mamífero e método para tratar dor em um mamífero
WO2013020600A1 (fr) * 2011-08-11 2013-02-14 Cross Sa Composition pharmaceutique comprenant un médicament contenant au moins une fonction toxicophore et de la n-acétyl-l-cystéine
KR101260636B1 (ko) 2012-11-29 2013-05-13 씨제이제일제당 (주) 안정화된 페메트렉시드 제제
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
KR101485243B1 (ko) 2013-05-08 2015-01-21 씨제이헬스케어 주식회사 안정화된 페메트렉시드 제제
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
US20190142789A1 (en) * 2017-08-09 2019-05-16 Piedmont Animal Health, Llc Therapeutic formulations and uses thereof
WO2021048748A1 (fr) 2019-09-09 2021-03-18 Ftf Pharma Private Limited Formulations pharmaceutiques contenant du diclofénac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
CN110872942B (zh) * 2019-10-24 2021-09-28 中国石油化工股份有限公司 油藏注采耦合方式下不同作用力对采收率贡献的研究方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
EP0785780A1 (fr) * 1994-10-10 1997-07-30 Novartis AG Compositions ophtalmiques et auriculaires contenant du diclofenac sel de potassium
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
WO1996041646A2 (fr) * 1995-06-13 1996-12-27 Dyer, Alison, Margaret Compositions pharmaceutiques contenant du lornoxicam et de la cyclodextrine
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP1173245B1 (fr) * 1999-05-03 2004-09-01 Battelle Memorial Institute Compositions destinees a la dispersion par aerosol et a l'inhalation
DE50104197D1 (de) * 2000-12-28 2004-11-25 Fresenius Kabi Austria Gmbh Gr Stabile Infusionslösung von Diclofenac-Salzen, deren Herstellung und Verwendung
DE60305438T2 (de) * 2002-02-01 2006-12-21 Shimoda Biotech (Pty.) Ltd., Mill Park Lyophilisierte pharmazeutische zusammensetzung von propofol
CA2477044A1 (fr) * 2002-02-22 2003-09-04 Pharmacia Corporation Formulation ophtalmique contenant un systeme de gomme

Also Published As

Publication number Publication date
PL1767219T3 (pl) 2010-06-30
DK1574221T3 (da) 2007-07-16
DE602004025151D1 (de) 2010-03-04
CA2555429C (fr) 2010-05-18
EP1574221A1 (fr) 2005-09-14
US20050238674A1 (en) 2005-10-27
KR20070028331A (ko) 2007-03-12
AU2004317520A1 (en) 2005-10-06
ZA200805860B (en) 2009-05-27
DE602004006952D1 (de) 2007-07-26
DK1767219T3 (da) 2010-05-10
PL1574221T3 (pl) 2007-10-31
CA2555429A1 (fr) 2005-10-06
PT1767219E (pt) 2010-02-15
ATE454905T1 (de) 2010-01-15
DE602004006952T2 (de) 2008-02-14
ES2336034T3 (es) 2010-04-07
CY1106824T1 (el) 2012-05-23
IL177529A (en) 2013-08-29
SI1574221T1 (sl) 2007-10-31
EP1767219A3 (fr) 2007-04-25
ES2287658T3 (es) 2007-12-16
BRPI0418474A (pt) 2007-06-19
US20120142779A1 (en) 2012-06-07
MXPA06010336A (es) 2007-02-16
WO2005092387A1 (fr) 2005-10-06
SI1767219T1 (sl) 2010-03-31
EP1767219B1 (fr) 2010-01-13
JP2007528384A (ja) 2007-10-11
PT1574221E (pt) 2007-07-09
ATE364402T1 (de) 2007-07-15
WO2005086763A3 (fr) 2006-03-02
EP1574221B1 (fr) 2007-06-13
WO2005086763A2 (fr) 2005-09-22
ZA200607631B (en) 2008-10-29
AU2004317520B2 (en) 2011-06-09
IL177529A0 (en) 2006-12-10
EP1767219A2 (fr) 2007-03-28

Similar Documents

Publication Publication Date Title
IL177529A0 (en) Stable injectable diclofenac compositions
TW200728307A (en) Novel spirochromanone derivatives
WO2007002559A8 (fr) Modulateurs des lxr a base de pyrazoles
WO2009146024A8 (fr) Analogues d’étomidate ayant des propriétés pharmacocinétiques et pharmacodynamiques améliorées
MX2007004699A (es) Derivados de indol y bencimidazol.
TW200637810A (en) Substituted N-aminomethylenesulfonamides, their preparation and use as medicaments
NZ593110A (en) pteridinone derivatives as MODULATORS OF TOLL-LIKE RECEPTORS
TW200603783A (en) Non-nucleoside reverse transcriptase inhibitors
PT2310356E (pt) Derivados de adamantildiamida e a sua utilização
WO2010030704A3 (fr) Analogues d’aminoglycosides antibactériens
MY145074A (en) Thiazolidin-4-one derivatives
WO2008048589A3 (fr) Composés et procédés pour le traitement du virus de l'hépatite c
WO2007131907A3 (fr) Dérivés de 1h-indol-5-yl-pipérazin-1-yl-méthanone
TW200621785A (en) Analgesic
UA104420C2 (uk) Застосування похідних глутарової кислоти або їх фармацевтично прийнятних солей як протиаритмічних засобів
WO2008063548A3 (fr) Dérivés de 3-(hétéro)arylisoquinolinamine substitués en position 5, 6, ou 7 et utilisation thérapeutique de ceux-ci
WO2008054767A3 (fr) Modifications en n4 d'analogues de pyrimidine et leurs utilisations
WO2007000655A3 (fr) Nouveaux dérivés de pyrazolopyrimidinone
WO2009053654A3 (fr) Prodrogues phosphoesters de la gemcitabine comme agents anticancereux
MY150776A (en) Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria
WO2007047881A3 (fr) Methode de traitement de la douleur
WO2007121471A3 (fr) Agents d'administration des éthers dialkyliques
WO2007143587A8 (fr) Procédés d'administration de médicament
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
WO2009021991A9 (fr) Utilisation d'acide r(+)-alpha-lipoïque dans la neuropathie cryptogénétique

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181130